Everest Medicines Limited 雲頂新耀有限公司
Pay for financial year ended 2022-12-31
Name | Last position |
Fees | Salary & benefits |
Bonus | Retire | Share- based |
Total | |
---|---|---|---|---|---|---|---|---|
CNY '000 |
||||||||
Directors |
||||||||
1 | Blanchard, Kerry Levan | CEO | 5,960 | 5,250 | 7,107 | 18,317 | ||
2 | Fu, Wei (1982) 傅唯 | Ch | ||||||
3 | Gong, Yubo 龔聿波 | NED | ||||||
4 | Jiang, Shidong (1968) 蔣世東 | INED | 336 | 273 | 609 | |||
5 | Kang, Lan 康嵐 | NED | ||||||
6 | Li, Yifan (1967) 李軼梵 | INED | 336 | 273 | 609 | |||
7 | Luo, Yongqing (1969) 羅永慶 | CEO | 2,102 | 1,310 | 16 | 4,574 | 8,002 | |
8 | Tan, Bo (1973) 譚擘 | INED | 336 | 273 | 609 | |||
9 | Woo, Ian Ying 何穎 | Pres, FD | 5,114 | 5,142 | 123 | 11,145 | 21,524 | |
10 | Zhang, Xiaofan (SFC:ANY097) 張曉帆 | ED, COO | 4,848 | 2,425 | 11,785 | 19,058 | ||
Total | 1,008 | 18,024 | 14,127 | 139 | 35,430 | 68,728 |
Main board pay history
Click on the year-end to see the pay details.
CNY'000
Year-end | Fees | Salary & benefits |
Bonus | Retire | Share- based |
Total | |
---|---|---|---|---|---|---|---|
2023-12-31 | 1,056 | 14,303 | 9,114 | 208 | 17,668 | 42,349 | Report |
2022-12-31 | 1,008 | 18,024 | 14,127 | 139 | 35,430 | 68,728 | Report |
2021-12-31 | 966 | 18,058 | 21,102 | 0 | 66,261 | 106,387 | Report |
2020-12-31 | 276 | 12,438 | 26,680 | 27 | 44,441 | 83,862 | Report |
Total | 3,306 | 62,823 | 71,023 | 374 | 163,800 | 301,326 |
Want to see more years here? volunteer to be a Webb-site editor and add the data from annual reports!
Sign up for our free newsletter
Recommend Webb-site to a friend
Copyright & disclaimer, Privacy policy